This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2007 Sep;164(9):1436-7.

doi: 10.1176/appi.ajp.2007.07030469.

Aripiprazole-induced tardive dyskinesia: the role of tamoxifen

Yesne Alici Evcimen, Harun Evcimen, Jimmie Holland

PMID: 17728431
DOI: 10.1176/appi.ajp.2007.07030469

Case Reports

Aripiprazole-induced tardive dyskinesia: the role of tamoxifen

Yesne Alici Evcimen et al. Am J Psychiatry. 2007 Sep.

. 2007 Sep;164(9):1436-7.

doi: 10.1176/appi.ajp.2007.07030469.

Authors

Yesne Alici Evcimen, Harun Evcimen, Jimmie Holland

PMID: 17728431
DOI: 10.1176/appi.ajp.2007.07030469

No abstract available

PubMed Disclaimer

Similar articles

Tardive dyskinesia due to aripiprazole: report of 2 cases.
Lungu C, Aia PG, Shih LC, Esper CD, Factor SA, Tarsy D. Lungu C, et al. J Clin Psychopharmacol. 2009 Apr;29(2):185-6. doi: 10.1097/JCP.0b013e31819a4bd5. J Clin Psychopharmacol. 2009. PMID: 19512985 No abstract available.
Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
Crismon ML, DeLeon A, Miller AL. Crismon ML, et al. Ann Pharmacother. 2003 May;37(5):738-40. doi: 10.1345/aph.1D014. Ann Pharmacother. 2003. PMID: 12708954 No abstract available.
A case of aripiprazole and tardive dyskinesia.
Abbasian C, Power P. Abbasian C, et al. J Psychopharmacol. 2009 Mar;23(2):214-5. doi: 10.1177/0269881108089591. Epub 2008 May 30. J Psychopharmacol. 2009. PMID: 18515468
Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
Moseley CN, Simpson-Khanna HA, Catalano G, Catalano MC. Moseley CN, et al. Clin Neuropharmacol. 2013 Jul-Aug;36(4):128-30. doi: 10.1097/WNF.0b013e31829b99d9. Clin Neuropharmacol. 2013. PMID: 23860346 Review.
Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
Keck PE Jr, McElroy SL. Keck PE Jr, et al. Expert Opin Investig Drugs. 2003 Apr;12(4):655-62. doi: 10.1517/13543784.12.4.655. Expert Opin Investig Drugs. 2003. PMID: 12665420 Review.

See all similar articles

Cited by

Tardive dyskinesia: treatment with aripiprazole.
Kang NR, Kim MD. Kang NR, et al. Clin Psychopharmacol Neurosci. 2011 Apr;9(1):1-8. doi: 10.9758/cpn.2011.9.1.1. Epub 2011 Apr 30. Clin Psychopharmacol Neurosci. 2011. PMID: 23430384 Free PMC article.
Treatment of neurolept-induced tardive dyskinesia.
Jankelowitz SK. Jankelowitz SK. Neuropsychiatr Dis Treat. 2013;9:1371-80. doi: 10.2147/NDT.S30767. Epub 2013 Sep 16. Neuropsychiatr Dis Treat. 2013. PMID: 24072972 Free PMC article. Review.
Aripiprazole (abilify) and tardive dyskinesia.
Schwartz T, Raza S. Schwartz T, et al. P T. 2008 Jan;33(1):32-4. P T. 2008. PMID: 19749988 Free PMC article.
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.
Kim J, Macmaster E, Schwartz TL. Kim J, et al. Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014. Drugs Context. 2014. PMID: 24744806 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.